Oxford University might have just achieved the biggest breakthrough till date in the fight against COVID-19. The prospective COVID-19 vaccine developed by Oxford and AstraZeneca is safe and has induced immune response in the volunteers. The preliminary report of phase 1/2 of human trials of the vaccine was published in the medical journal ‘The Lancet’ on Monday, June 20.
The prospective COVID-19 vaccine has been developed by Oxford’s Jenner Institute and has been backed by the UK-based global biopharmaceutical company AstraZeneca. The vaccine had moved into phase 2/3 trials in the month of May.
The researchers have said that they have found that their experimental COVID-19 vaccine has produced dual immune response in people aged 18 to 55 years who weren’t infected by Coronavirus previously.
This comes as a huge ray of hope for the world which has been battling the worst pandemic in recent history, where thousands of people all over the world have lost their lives.